| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |